SCHEMBL29068615

SCHEMBL29068615

O=C(OC1CCCCCNNN1)c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNA7 P36544 3/20 0.43
CHRM2 P08172 2/20 0.42
CHRM4 P08173 2/20 0.42
CHRM1 P11229 2/20 0.42
CHRM3 P20309 2/20 0.42
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
SLC18A3 Q16572 1/20 0.40
GAA P10253 1/20 0.40
HTR3E A5X5Y0 1/20 0.39
HTR3B O95264 1/20 0.39
HTR3A P46098 1/20 0.39
HTR3D Q70Z44 1/20 0.39
HTR3C Q8WXA8 1/20 0.39
LMNA P02545 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2D6 P10635 1/20 0.39
SCN1A P35498 1/20 0.39
SCN2A Q99250 1/20 0.39
SCN3A Q9NY46 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11056537 0.84 CHRNA7 (0.49) CHRNA7CHRM2CHRM4CHRM1CHRM3
SCHEMBL26105561 0.82 CHRNA7 (0.50) CHRNA7CHRM2CHRM4CHRM1CHRM3
SCHEMBL27301151 0.77 CHRNA7 (0.51) CHRNA7CHRM2CHRM4CHRM1CHRM3
SCHEMBL27499699 0.75 CHRNA7 (0.56) CHRNA7CHRM2CHRM4CHRM1CHRM3
SCHEMBL14720174 0.72 MEN1 (0.63) CHRNA7MEN1KMT2AGAAHTR3E
SCHEMBL11592049 0.72 MEN1 (0.63) CHRNA7MEN1KMT2AGAAHTR3E
SCHEMBL60478 0.72 MEN1 (0.63) CHRNA7MEN1KMT2AGAAHTR3E
SCHEMBL31139240 0.72 MEN1 (0.63) CHRNA7MEN1KMT2AGAAHTR3E
SCHEMBL29068614 0.71 CHRNA7 (0.52) CHRNA7CHRM3MEN1KMT2AGAA
Ammonia Solution, Strong SCHEMBL597060 0.71 MEN1 (0.61) CHRNA7MEN1KMT2AGAAHTR3E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116745292-A Substituted pyridotriazine compounds and uses thereof 吉利德科学公司 2023-09-12 CN disclosed